Downtrend on the daily chart: below its 200-day average, above its 50-day · 50-day below the 200-day · SuperTrend down since Jun 11 · inside the Ichimoku cloud · RSI 53 · MACD above its signal
None of the 29 investors followed here reported a position in AFJK in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a AFJK trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 10, 2025 | Mizuho Securities Usa, Llc.Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.86 per share. | 150K | $1.63M |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -17.8 | -38.6 | -24.2 | 78.4 | -3.9 | -27.9 | -60.3 | -0.2 | 0.8 | 3.2 | −80.5% | ||
| 2025 | 0.5 | 1.9 | 0.4 | 0.3 | 1.0 | 0.1 | 1.3 | 0.0 | 0.2 | 1.1 | -6.9 | 501.0 | +498.2% |
| 2024 | -0.3 | 1.0 | 0.0 | 0.6 | 0.3 | 0.4 | 0.5 | 0.4 | 1.0 | 0.3 | 0.8 | +5.1% |
No analyst coverage for this instrument.
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
No recent headlines.